gemcitabine has been researched along with Hyperammonemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huitema, ADR; Otten, HM; Verkerk, K | 1 |
| Chapuy, CI; Kozyreva, ON; Sahai, I; Sharma, R; Zhu, AX | 1 |
2 other study(ies) available for gemcitabine and Hyperammonemia
| Article | Year |
|---|---|
Idiopathic hyperammonemic encephalopathy secondary to gemcitabine-cisplatin treatment.
Topics: Antineoplastic Agents; Asparaginase; Brain Diseases; Cisplatin; Cytarabine; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Hyperammonemia; Neurotoxicity Syndromes | 2022 |
Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
Topics: Adult; Brain Diseases; Carcinoma, Hepatocellular; Deoxycytidine; Gemcitabine; Humans; Hyperammonemia; Liver Neoplasms; Male; Organoplatinum Compounds; Ornithine Carbamoyltransferase Deficiency Disease; Oxaliplatin | 2016 |